Co-Abuse Cannabis and Tobacco
Co-Abuse Cannabis and Tobacco
批准号:
10219459
负责人:
JENNY L. WILEY
金额:
$20.4万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2022-07-31
关键词:
AcuteAddressAdultAlkaloidsBehaviorCannabisCannabis AbuseCharacteristicsCigaretteDataData CollectionDevelopmentDisciplineDiseaseDoseDrug usageEducationElectronic cigaretteEpidemiologyFemaleGoalsHealthHumanIndividualInhalationLaboratory StudyLegalLiteratureMarijuana DependenceMarijuana SmokingMeasuresMethodsMinorModelingMusNicotineOutcomeOutpatientsPatternPharmaceutical PreparationsPhasePlacebosPreventionProceduresPsychological reinforcementPublic HealthRelative RisksResearchRiskRouteSelf AdministrationSiteSmokerSpecialistSumSurveysTetrahydrocannabinolTimeTobaccoTobacco Use CessationTobacco smoking behaviorTobacco useTrainingTranslational ResearchUnited StatesValidationbehavioral pharmacologycravingepidemiologic dataepidemiology studyhookahinsightmalemarijuana legalizationmarijuana usemarijuana use disordermouse modelnicotine inhalationnon-smokernovelpre-clinicalpreventable deathpsychosocialsocial mediatargeted treatmenttobacco productstobacco smokerstobacco usertrend
中文摘要
项目摘要
烟草和大麻是美国最常滥用的两种物质。此外,本发明还
同时使用大麻和烟草多种物质的情况并非不多,而且呈上升趋势
因为大麻的使用在越来越多的国家合法化。这种上升趋势尤其令人关注
因为,与不使用烟草的大麻相比,CT-PSU与更大的大麻有关
依赖、心理社会问题和较差的戒烟结果,以及附加的健康风险,
相对于单独的物质。确定CT-PSU的基本机制将需要协调
流行病学、临床前和人体实验室研究。然而,每个学科中的模型和度量
最常用于检查CT-PSU的方法是为了研究单一药物的使用,
捕捉CT-PSU的独特功能。在拟议的项目中,CT-PSU的模式将通过
制定和实施专门针对CT-PSU(R21阶段)的新调查措施。在
此外,还将建立和验证小鼠吸入尼古丁自我给药的程序
同时收集流行病学数据。随后,这两项努力的结果将指导决策
关于用于研究Δ9-四氢大麻酚(THC;
大麻的主要精神活性替代物)对吸入尼古丁的增强作用(即,“追逐”)和
同时施用的两种药物的增强作用(例如,如在钝头或钝头中)在小鼠和人中
吸烟者和不吸烟者。这一具有指导意义的做法将导致建立
更好的模型,通过它来调查CT-PSU,最终目标是发现其潜在的
机制和发展有针对性的治疗方法。
英文摘要
PROJECT SUMMARY
Tobacco and cannabis are two of the most commonly abused substances in the United States. Further,
simultaneous cannabis and tobacco polysubstance use (CT-PSU) is not insubstantial and is trending upwards
as cannabis use is legalized in an increasing number of states. This upward trend is of particular concern
because, compared to use of cannabis without tobacco, CT-PSU is associated with greater cannabis
dependence, psychosocial problems, and poorer cessation outcomes, as well as with additive health risks,
relative to either substance alone. Determination of mechanisms underlying CT-PSU will require coordinated
epidemiological, preclinical, and human laboratory studies. Yet, the models and measures in each discipline
that are used most often to examine CT-PSU were developed to investigate single drug use and may not
capture unique features of CT-PSU. In the proposed project, patterns of CT-PSU will be characterized through
development and implementation of novel survey measures that focus specifically on CT-PSU (R21 phase). In
addition, a procedure for inhaled nicotine self-administration in mice will be established and validated
simultaneously with epidemiological data collection. Subsequently, results from both efforts will guide decisions
regarding experimental parameters to be used to investigate the effects of Δ9-tetrahydrocannabinol (THC;
primary psychoactive substituent of cannabis) on inhaled nicotine’s reinforcing effects (i.e., “chasing”) and the
reinforcing effects of both drugs administered simultaneously (e.g., as in blunts or spliffs) in mice and in human
tobacco smokers and non-smokers. This translationally relevant approach will result in the establishment of
better models through which to investigate CT-PSU, with the ultimate goals of discovery of its underlying
mechanisms and development of targeted treatment approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics
-
批准号:9895190
-
项目类别:
-
资助金额:$48.76万
-
财政年份:2019
-
负责人:JENNY L. WILEY
-
依托单位:
Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics
-
批准号:10015203
-
项目类别:
-
资助金额:$47.05万
-
财政年份:2019
-
负责人:JENNY L. WILEY
-
依托单位:
Co-Abuse Cannabis and Tobacco
-
批准号:9374588
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2017
-
负责人:JENNY L. WILEY
-
依托单位:
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences
-
批准号:9899222
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2016
-
负责人:JENNY L. WILEY
-
依托单位:
ICRS Symposium on the Cannabinoids
-
批准号:8588474
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:JENNY L. WILEY
-
依托单位:
ICRS Symposium on the Cannabinoids
-
批准号:8646900
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:JENNY L. WILEY
-
依托单位:
ICRS Symposium on the Cannabinoids
-
批准号:8828143
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:JENNY L. WILEY
-
依托单位:
Behavioral Pharmacology of Synthetic Cannabinoids
-
批准号:8269961
-
项目类别:
-
资助金额:$9.88万
-
财政年份:2011
-
负责人:JENNY L. WILEY
-
依托单位:
Behavioral Pharmacology of Synthetic Cannabinoids
-
批准号:8173411
-
项目类别:
-
资助金额:$9.87万
-
财政年份:2011
-
负责人:JENNY L. WILEY
-
依托单位:
Endocannabinoid Discrimination
-
批准号:8312603
-
项目类别:
-
资助金额:$30.38万
-
财政年份:2010
-
负责人:JENNY L. WILEY
-
依托单位:
Endocannabinoid Discrimination
-
批准号:8135573
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2010
-
负责人:JENNY L. WILEY
-
依托单位:
Endocannabinoid Discrimination
-
批准号:8719072
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2010
-
负责人:JENNY L. WILEY
-
依托单位:
Endocannabinoid Discrimination
-
批准号:8526441
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2010
-
负责人:JENNY L. WILEY
-
依托单位:
Developmental Pharmacology of Cannabinoids
-
批准号:6770849
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
Developmental Pharmacology of Cannabinoids
-
批准号:7213404
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
Sex Differences in Cannabinoid Dependence and Analgesia
-
批准号:8542804
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
Developmental Pharmacology of Cannabinoids
-
批准号:6871360
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
Developmental Pharmacology of Cannabinoids
-
批准号:7013226
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
Sex Differences in Cannabinoid Dependence and Analgesia
-
批准号:8739924
-
项目类别:
-
资助金额:$10.69万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
Sex Differences in Cannabinoid Dependence and Analgesia (parent grant)
-
批准号:9006260
-
项目类别:
-
资助金额:$21.36万
-
财政年份:2004
-
负责人:JENNY L. WILEY
-
依托单位:
海外基金